Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-19-015443
Date:2019-05-30
Issuer: AMEDISYS INC (AMED)
Original Submission Date:

Reporting Person:

KEMMERLY DAVID L
3854 AMERICAN WAY, SUITE A
BATON ROUGE, LA 70816

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-30 M 3,750 a $27.35 26,274 direct
COMMON STOCK 2019-05-30 M 1,250 a $27.35 27,524 direct
COMMON STOCK 2019-05-30 S 5,000 d $113.48 22,524 direct
COMMON STOCK 2019-05-30 0 $0.00 445 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 27.35 2019-05-30 deemed execution date M 3,750 (d) 2025-05-01 common stock 3,750 $27.35 18,750 direct
STOCK OPTION (RIGHT TO BUY) 27.35 2019-05-30 deemed execution date M 1,250 (d) 2025-05-01 common stock 1,250 $27.35 1,875 direct
Footnotes
IDfootnote
f1 the total amount of shares beneficially owned includes 219 shares held in an employee stock purchase plan account.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $113.32 to $113.60, inclusive. the reporting person undertakes to provide to amedisys, inc. (the "issuer"), any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this form 4.
f3 the information in this report is based on a plan statement dated as of march 31, 2019.
f4 on may 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. the options are subject to time-based vesting conditions. 18,750 of the options vested on may 1, 2019, and the remaining 18,750 options will vest on may 1, 2020, provided that the reporting person remains continuously employed by the issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the options. after the transaction being reported herein, the reporting person has exercised all 18,750 of the vested options.
f5 on may 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. the option vests based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending december 31, 2015, 2016, 2017 and 2018. the performance criteria for 2016 were met, resulting in vesting of the option as to 9,375 shares (the "2016 tranche options"), subject to additional time-based vesting as follows: one-third of the 2016 tranche options vested on may 1, 2017, one-third of the 2016 tranche options vested on may 1, 2018 and one-third of the 2016 tranche options vested on may 1, 2019. after the transaction being reported herein, the reporting person has exercised 7,500 of the 2016 tranche options.
WhaleWisdom Logo

Elevate your investments